Showing results (301-310 of 312) with videos related to

Sort By:
Pageof 32
Plos One|March 30, 2012
SCD1 inhibition causes cancer cell death by depleting mono-unsaturated fatty acidsPaul Mason, Beirong Liang, Lingyun Li, et al.
Chemical Science|October 3, 2025
Design, modular synthesis and screening of 58 shape-diverse 3-D fragmentsThomas D Downes, S Paul Jones, James D Firth, et al.
The Journal of Bone and Joint Surgery. American Volume|August 22, 2014
Development and initial validation of the Classification of Early-Onset Scoliosis (C-EOS)Brendan A Williams, Hiroko Matsumoto, Daren J McCalla, et al.
Journal of Medicinal Chemistry|April 20, 2018
Discovery of Allosteric, Potent, Subtype Selective, and Peripherally Restricted TrkA Kinase InhibitorsSharan K Bagal, Kiyoyuki Omoto, David C Blakemore, et al.
The Journal of Bone and Joint Surgery. American Volume|May 17, 2013
Evaluating the extent of clinical uncertainty among treatment options for patients with early-onset scoliosisJacqueline Corona, Daniel J Miller, Jenny Downs, et al.
The Journal of Bone and Joint Surgery. American Volume|November 16, 2023
The Effect of Implant Density on Adolescent Idiopathic Scoliosis Fusion: Results of the Minimize Implants Maximize Outcomes Randomized Clinical TrialA Noelle Larson, David W Polly, Paul D Sponseller, et al.
Chemmedchem|April 15, 2014
The discovery of potent nonstructural protein 5A (NS5A) inhibitors with a unique resistance profile-Part 2Florian Wakenhut, Thien Duc Tran, Chris Pickford, et al.
Bioorganic & Medicinal Chemistry Letters|October 15, 2017
Highly potent and selective NaV1.7 inhibitors for use as intravenous agents and chemical probesR Ian Storer, Andy Pike, Nigel A Swain, et al.
Journal of Medicinal Chemistry|June 27, 2018
Discovery of Potent, Selective, and Peripherally Restricted Pan-Trk Kinase Inhibitors for the Treatment of PainSharan K Bagal, Mark Andrews, Bruce M Bechle, et al.
Pageof 32